Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.50%
1,075.15
-16.36
-1.50%
—1,091.511,090.401,090.401,074.65——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
608.12
-1.99
-0.33%
—610.11610.11610.29606.17——
SIXE
Energy
SIXE
Energy
SIXE
+0.87%
1,248.74
+10.76
+0.87%
—1,237.981,237.831,252.411,225.03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.10%
1,725.60
-19.11
-1.10%
—1,744.711,740.951,747.291,721.57——
SIXM
Financials
SIXM
Financials
SIXM
-0.70%
635.72
-4.46
-0.70%
—640.18639.92643.19634.73——
SIXR
Staples
SIXR
Staples
SIXR
-1.08%
840.42
-9.16
-1.08%
—849.58845.27851.68840.00——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.78%
215.78
-1.70
-0.78%
—217.48217.48218.16215.51——
SIXT
Technology
SIXT
Technology
SIXT
+0.10%
3,263.96
+3.27
+0.10%
—3,260.693,273.363,287.813,240.78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.65%
936.31
-6.14
-0.65%
—942.45939.39948.80933.98——
SIXV
Health care
SIXV
Health care
SIXV
-0.24%
1,463.28
-3.52
-0.24%
—1,466.801,464.701,467.191,458.36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.80%
2,378.24
-19.26
-0.80%
—2,397.502,395.032,412.012,370.64——
REPCF:OTCMKTS
RepliCel Life Sciences Inc
$0.00010
0.00%
(0.00) 1D
Apr 6, 12:04:36 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REPCF...
Mkt. cap
7.35K
Volume
0.00
52-wk high
$0.00
52-wk low
$0.00
EPS
-$0.08
Shares outstanding
73.58M
No. of employees
1
News stories
From sources across the web
Profile
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle. The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. Wikipedia
About RepliCel Life Sciences Inc
CEO-
Employees1
Founded1967
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websitereplicel.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
43.80K
-
2.31K
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99.71K
21.72K
5.25K
-
Operating expense
143.51K
21.72K
7.56K
-
Total operating expenses
143.51K
21.72K
7.56K
-
Operating income
-143.51K
-21.72K
-7.56K
-
Other non operating income
3.47M
-
-
-
EBT including unusual items
-8.22M
-28.65K
-25.10K
-
EBT excluding unusual items
3.32M
-28.65K
-25.10K
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.22M
-28.65K
-25.10K
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-6.93K
-17.54K
-
Net interest expenses
-
-6.93K
-17.54K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-143.37K
-21.58K
-7.42K
-
Gain or loss from assets sale
11.58M
1.65K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer